Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NewSelf vs Rewinding RX

NewSelf
Graded #18

Higher grade

vs+26.099999999999994
Rewinding RX
Graded #340

Lower grade

The verdict

NewSelf takes it — 85.6/100 to 59.5/100.

NewSelf grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide, $144 tirzepatide, verified and available in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNewSelf +48
93
45
Dose & formulationNewSelf +40
80
40
Clinical oversightRewinding RX +1
84
85
Labs & monitoringNewSelf +29
82
53
FulfillmentEven
87
87
Contract termsNewSelf +24
85
61
NewSelf · left barRewinding RX · right bar

The numbers

MetricNewSelfRewinding RX
WeighScore85.6/10059.5/100
GradeBC
Scorecard rank#18#340
Semaglutide$100/moNot disclosed
Tirzepatide$144/moNot disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
NewSelf

Graded #18 · B

Strengths

  • $100 sema / $144 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Injection-only
  • Labs/monitoring detail sparse
  • Limited brand history
Rewinding RX

Graded #340 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer — uncommon transparency
  • MD-only physician network ('never a physician assistant or nurse')
  • All-50-state coverage with physician state-licensing matching
  • Corporate entity disclosed (Rewinding RX Ltd.)

Where it loses points

  • Pricing not shown — fully gated behind sign-up
  • Pharmacy partner not named (only generic 503A/503B references)
  • Medical director / clinical leadership not disclosed
  • Governing law, arbitration venue, and corporate address not disclosed
  • Tirzepatide not listed on the homepage (semaglutide only confirmed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard